Bone marrow stromal damage after chemo/radiotherapy: Occurence, consequences and possibilities of treatment

Leukemia and Lymphoma

Volumn 42, Issue 5, 2001, Pages 863-870

  Banfi, A ^a   Bianchi, G ^a   Galotto, M ^a   Cancedda, R ^a   Quarto, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Bone marrow stromal cells; Chemotherapy; Marrow stroma; Stroma transplant

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN; CYTOTOXIC AGENT; GLUCOCORTICOID;

BONE MARROW DISEASE; BONE MARROW TRANSPLANTATION; BONE METABOLISM; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COLONY FORMING UNIT F; CONTROLLED STUDY; DRUG MEGADOSE; ENVIRONMENT; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOSTASIS; HUMAN; NONHODGKIN LYMPHOMA; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SOLID TUMOR; STEM CELL TRANSPLANTATION; STROMA CELL; WHOLE BODY RADIATION;

EID: 0034839686     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097705     Document Type: Review

References (82)

1. The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rats
2. Conditions controlling the proliferation of haemopoietic stem cells in vitro
3. The ultrastructure of the hemopoietic environment of the marrow: A review
4. Hemopoietic stromal microenvironment
5. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo
6. Long-term marrow culture: An overview of techniques and experience
7. Characterization of the in vitro stromal microenvironment of human bone marrow
8. CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures
9. Marrow stromal stem cells
10. Osteogenic stem cells and the stromal system of bone and marrow
11. Osteogenic stem cells in the bone marrow
12. Marrow biology and stem cells
13. Stromal cell associated haemopoiesis
14. Mesenchymal stem cell
15. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures
16. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts
17. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow
18. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells
19. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo
20. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse
21. Differentiation potentials of clonal strains of bone marrow fibroblasts
22. Repair of bone defects with marrow cells and porous ceramic. Experiments in rat
23. The osteogenic potential of cultured-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks
24. Human bone tissue formation in diffusion chamber culture in vivo by bone derived cells and marrow stromal fibroblastic cells
25. Bone progenitor cell deficits and the age-associated decline in bone repair capacity
26. Multilineage potential of adult human mesenchymal stem cells
27. Diseases of bone and the stromal cell lineage
28. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in 1998
29. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients
30. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors
31. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation
32. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture
33. Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation
34. The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function
35. Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation
36. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy
37. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients
38. Bone marrow regeneration after local injury: A review
39. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma
40. Residual marrow damage following therapy with cyclophosphamide
41. Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors
42. The cellular basis of long-term marrow injury after irradiation
43. An analysis of haemopoietic and microenvironmental populations of mouse bone marrow after treatment with busulphan
44. A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide
45. Toxic effects on the hematopoietic microenvironment
46. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation
47. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation
48. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients
49. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery
50. Hemopoietic reconstitution after bone marrow transplantation
51. Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: Recovery of haemopoietic progenitors (CFU-Mix, BFU-E and CFU-GM)
52. Clonogenic hemopoietic precursors in bone marrow transplantation
53. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation
54. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation
55. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation
56. Reduction of bone mass in women after bone marrow transplantation
57. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies
58. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation
59. Bone mineral density after allogeneic bone marrow transplantation
60. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin
61. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma
62. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study
63. Osteoporosis after blood and marrow transplantation: Clinical aspects
64. Mechanisms of osteoporosis after hematopoietic cell transplantation
65. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by plus bones (stromal cells) from the same donor
66. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice
67. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
68. Human menchymal stem cells suppress allogeneic T cell responses in vitro: Implications for allogeneic transplantation
69. Reconstitution of haemopoietic system with autologous marrow taken during relapse of acute myeloblastic leukaemia and grown in long-term culture
70. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture
71. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use
72. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
73. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice
74. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation
75. Donor stromal cells from human blood engraft in NOD/SCID mice
76. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep
77. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation
78. Host origin of marrow stromal cells following allogeneic bone marrow transplantation
79. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia
80. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
81. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model
82. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy